KOMIPHARM
LIVE

Serial Number

79172263

Owner

Komipharm International Co., Ltd.

Attorney

Yoon S. Ham

Filing Date

May 8, 2015

Add to watchlist:

No watchlists yet
View on USPTO

KOMIPHARM Trademark

Serial Number: 79172263 • Registration: 5084132

KOMIPHARM is a trademark filed by Komipharm International Co., Ltd. on May 8, 2015. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

Komipharm International Co., Ltd. (5 trademarks)

1 Ra-107, Sihwa Industrial Complex,
Gyeonggi-do , KR

Entity Type: 99

Trademark Details

Filing Date

May 8, 2015

Registration Date

November 22, 2016

Published for Opposition

September 6, 2016

Cancellation Date

May 9, 2025

Goods & Services

Disinfectants for hygiene purposes; Veterinary preparations, namely, pain relief medication, medication for treatment of intestinal bacteria, antioxidants; Deodorizing preparations for household, commercial or industrial use for pet litter boxes, carpets; Household deodorant; Insecticides; Germicides; Insect repellents; Medicines for veterinary purposes, namely, medicines for treatment of porcine circoviral disease, porcine epidemic diarrhea, transmissible gastroenteritis, rotavirus infection pasteurellosis, pleuropneumoniae, classical swine fever, swine erysipelas, swine mycoplasmoses, akabane disease, pasteurellosis, colibacillosis, bovine ephemeral fever, newcastle disease, infectious bronchitis, low pathogenicity avian influenza, infectious bursal disease, salmonellosis, rabies, canine distemper, infectious canine hepatitis, parvovirus infection, coronavirus infection, leptospirosis; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Antibiotic preparations; Chemotherapeutics; Tumor suppressing agents; Pharmaceutical preparations acting on the central nervous system; Cardiovascular pharmaceutical preparations; Pharmaceutical agents affecting metabolism; Chemical preparations for pharmaceutical purposes, namely, for the treatment of pain and inflammation associated with cancer, the treatment of cancer, the treatment of leukemia and lymphoma, the treatment of metastatic neoplastic diseases, the treatment of brain tumors, cancer stem cell-targeted and drug resistant cancer therapy, the treatment of urogenital cancer and its metastasis; Biological preparations for the treatment of porcine circoviral disease, porcine epidemic diarrhea, transmissible gastroenteritis, rotavirus infection pasteurellosis, pleuropneumoniae, classical swine fever, swine erysipelas, swine mycoplasmoses, akabane disease, pasteurellosis, colibacillosis, bovine ephemeral fever, newcastle disease, infectious bronchitis, low pathogenicity avian influenza, infectious bursal disease, salmonellosis, rabies, canine distemper, infectious canine hepatitis, parvovirus infection, coronavirus infection, leptospirosis

Filing History

NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Nov 30, 2025 DENA
DEATH OF INTERNATIONAL REGISTRATION
Nov 30, 2025 DETH
NEW REPRESENTATIVE AT IB RECEIVED
May 23, 2025 NREP
TOTAL INVALIDATION PROCESSED BY THE IB
Mar 11, 2024 INNT
TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Feb 20, 2024 INTS
INVALIDATION PROCESSED
Feb 19, 2024 INPC
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Feb 9, 2024 INTR
CANCELLED SECTION 71
Jun 9, 2023 C71T
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Nov 22, 2021 REM3
FINAL DECISION TRANSACTION PROCESSED BY IB
Mar 25, 2017 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Mar 7, 2017 FICS
FINAL DISPOSITION PROCESSED
Mar 7, 2017 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Feb 22, 2017 FICR
REGISTERED-PRINCIPAL REGISTER
Nov 22, 2016 R.PR
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Sep 16, 2016 OPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 6, 2016 NPUB
PUBLISHED FOR OPPOSITION
Sep 6, 2016 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Aug 17, 2016 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Aug 17, 2016 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 17, 2016 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Aug 2, 2016 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 26, 2016 CNSA
EXAMINER'S AMENDMENT ENTERED
Jul 22, 2016 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jul 22, 2016 GNEN
EXAMINERS AMENDMENT E-MAILED
Jul 22, 2016 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jul 22, 2016 CNEA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Apr 21, 2016 GNRN
NON-FINAL ACTION E-MAILED
Apr 21, 2016 GNRT
NON-FINAL ACTION WRITTEN
Apr 21, 2016 CNRT
NOTIFICATION OF FINAL REFUSAL EMAILED
Apr 21, 2016 GNFN
FINAL REFUSAL E-MAILED
Apr 21, 2016 GNFR
FINAL REFUSAL WRITTEN
Apr 21, 2016 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 28, 2016 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 28, 2016 CRFA
ASSIGNED TO LIE
Mar 23, 2016 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 10, 2016 TROA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Feb 26, 2016 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Feb 26, 2016 REAP
REFUSAL PROCESSED BY IB
Oct 9, 2015 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Sep 18, 2015 RFCS
REFUSAL PROCESSED BY MPU
Sep 18, 2015 RFRR
APPLICATION FILING RECEIPT MAILED
Sep 18, 2015 MAFR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Sep 17, 2015 RFCR
NON-FINAL ACTION WRITTEN
Sep 16, 2015 CNRT
ASSIGNED TO EXAMINER
Sep 14, 2015 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 14, 2015 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Sep 10, 2015 REPR